CAR-T cell therapy leader
As of May 2023, Sheba's hospital CAR-T programs, initiated in 2016, have treated a total of 258 patients, becoming the largest CAR-T center in Europe. The treatments encompassed 189 adult and 69 pediatric patients. Among them, 189 were diagnosed with lymphatic malignancies, 32 had Multiple Myeloma, and 6 were identified with Acute Myeloid Leukemia (AML).
- About Sheba in-house CAR-T therapy
- What is the difference between Sheba’s in-house car-t therapy and other commercial car-t’s?
- Car-t cell therapy cost in Sheba hospital
- Understanding the costs of car-t therapy at Sheba hospital
- Overview of Sheba’s CAR-T activity - May 2023
- Why is the car-t cell therapy at Sheba medical center superior to others?
CAR-T in Israel - patients testimonials:
CAR-T patient testimonial:
CAR-T patient testimonial:
Doctor Abraham Avigdor, director of Sheba's Hematology department in an interview for Israeli TV. (Hebrew with English captions)
TV program. Hebrew with English subtitles. CAR-T therapy - new treatment for blood cancers and Lymphoma.
CAR T patients in Israel with our guide
Read more about the treatment:
